Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 142
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #225: Q1 Lobbying Update; Individual vs. Group MDMA Therapy Study Launches; Australia Loosens Psychedelics Access Regulations; VA Launches “New” MDMA Trial
Three Brain Injuries, One Iboga Protocol, and What It Tells Us
The War on Drugs Was Never About Drugs. Psychedelic Healing Must Reckon With That.
A Dispatch from APA’s Annual Meeting: Psychedelics Return at an Awkward Moment for American Psychiatry
Momentum Amidst Tumult: The FDA Reshuffle, Approval Timelines, and the Compass-Usona Race
Numinus Wellness Inc. Reports Q4 2022 and Annual Results
PsyBio Therapeutics Announces Non-Brokered Private Placement Financing
FILAMENT HEALTH ANNOUNCES NEW UNITED STATES PATENT ISSUANCES
Revive Therapeutics Ltd. Announces Offering of Up to $5 Million
Clearmind Announces Initiation of CMND-100 Manufacturing Program to Address its Upcoming...
Many Trips, Diminishing Returns: Cross-Tolerance Between LSD and DOI
PT375 – Microdosing & Citizen Science: Introducing the World’s First Take-Home...
Small Pharma to Participate in November Investor and Healthcare Conferences
Silo Pharma Initiates Study of Novel Joint Homing Peptide in Human...
Tryp Therapeutics Announces Poster Presentations on the Reduction of Chronic Pain...
Load more